Page last updated: 2024-09-04

resiquimod and lactic acid

resiquimod has been researched along with lactic acid in 2 studies

Compound Research Comparison

Studies (resiquimod)	Trials (resiquimod)	Recent Studies (post-2010) (resiquimod)	Studies (lactic acid)	Trials (lactic acid)	Recent Studies (post-2010) (lactic acid)
465	14	318	46,263	3,349	19,053

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bogdahn, U; Chirasani, SR; Gottfried, E; Grauer, OM; Gronwald, W; Hau, P; Hochrein, J; Kreutz, M; Leukel, P; Neumann, B; Oefner, PJ; Stadler, K	1
Allémann, E; Bourquin, C; Delie, F; Mottas, I; Nguyen, VN; Thauvin, C; Widmer, J	1

Other Studies

2 other study(ies) available for resiquimod and lactic acid

Article	Year
Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model. International journal of cancer, 2013, Feb-15, Volume: 132, Issue:4 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Marrow Cells; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dendritic Cells; Diclofenac; Disease Models, Animal; Female; Glioma; Imidazoles; Immune Tolerance; Interferon-gamma; Interleukin-10; Interleukin-12; Interleukin-2 Receptor alpha Subunit; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Lactic Acid; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Phosphorylation; T-Lymphocytes, Regulatory; Transcriptional Activation; Up-Regulation	2013
Polymer-based nanoparticles loaded with a TLR7 ligand to target the lymph node for immunostimulation. International journal of pharmaceutics, 2018, Jan-15, Volume: 535, Issue:1-2 Topics: Animals; Cell Line; Cell Survival; Imidazoles; Immunization; Lactic Acid; Ligands; Lymph Nodes; Macrophages; Membrane Glycoproteins; Mice, Inbred C57BL; Nanoparticles; Polyesters; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spleen; Toll-Like Receptor 7	2018

Article

Year

Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model.

International journal of cancer, 2013, Feb-15, Volume: 132, Issue:4

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Marrow Cells; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dendritic Cells; Diclofenac; Disease Models, Animal; Female; Glioma; Imidazoles; Immune Tolerance; Interferon-gamma; Interleukin-10; Interleukin-12; Interleukin-2 Receptor alpha Subunit; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Lactic Acid; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Phosphorylation; T-Lymphocytes, Regulatory; Transcriptional Activation; Up-Regulation

2013

Polymer-based nanoparticles loaded with a TLR7 ligand to target the lymph node for immunostimulation.

International journal of pharmaceutics, 2018, Jan-15, Volume: 535, Issue:1-2

Topics: Animals; Cell Line; Cell Survival; Imidazoles; Immunization; Lactic Acid; Ligands; Lymph Nodes; Macrophages; Membrane Glycoproteins; Mice, Inbred C57BL; Nanoparticles; Polyesters; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spleen; Toll-Like Receptor 7

2018